Lennernäs, Bo <br/><br/>
Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study.  [electronic resource] 

 -  Palliative medicine  Apr 2010 
 - 286-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-030X 
<br/><br/><label>Standard No.: </label>10.1177/0269216309356138  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Sublingual<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analgesics, Opioid--administration & dosage<br/>Cross-Over Studies<br/>Dizziness--chemically induced<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Fentanyl--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Neoplasms--complications<br/>Pain--drug therapy<br/>Pain Measurement--methods<br/>Placebos<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult